Cefoxitin and Tazidime drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefoxitin (cefoxitin sodium) and Tazidime (ceftazidime). Common drug interactions include gastrointestinal haemorrhage among females and acute respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Cefoxitin and Tazidime. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Cefoxitin?

Cefoxitin has active ingredients of cefoxitin sodium. eHealthMe is studying from 611 Cefoxitin users. Check the latest studies of Cefoxitin.

What is Tazidime?

Tazidime has active ingredients of ceftazidime. eHealthMe is studying from 10,409 Tazidime users. Check the latest studies of Tazidime.

On Aug, 02, 2026

12 people who take Cefoxitin and Tazidime together, and have interactions are studied.

Cefoxitin and Tazidime drug interactions.

What are the common drug interactions of Cefoxitin and Tazidime, by gender? *:

female:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Tonsillitis (inflammation of tonsil)
Upper respiratory tract infection
Bone marrow depression (decreased ability or inability of the bone marrow to produce blood cells)
Deafness neurosensory
Feeding disorder (when children refuse to eat certain food groups)
Gastroenteritis (inflammation of stomach and intestine)
Hepatic failure (liver failure)
Pleural effusion (water on the lungs)

male:

Acute respiratory failure
Acid fast bacilli infection (mycobacterium tuberculosis infection-hiv patient)
Candidiasis (candidiasis or thrush is a fungal infection)
Mycobacterium abscessus infection (rapid growing bacterial infection)
Nausea (feeling of having an urge to vomit)
Osteonecrosis (death of bone)
Vomiting
Wound infection

What are the common drug interactions of Cefoxitin and Tazidime, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Deafness neurosensory
Feeding disorder (when children refuse to eat certain food groups)
Gastroenteritis (inflammation of stomach and intestine)
Mycobacterium abscessus infection (rapid growing bacterial infection)
Nausea (feeling of having an urge to vomit)
Osteonecrosis (death of bone)
Pleural effusion (water on the lungs)
Vomiting
Wound infection
Gastritis (inflammation of stomach)

20-29:

Acute respiratory failure

30-39:

n/a

40-49:

n/a

50-59:

Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain)
Pneumonia

60+:

n/a

What are the existing conditions these people have? *

Spinal Muscular Atrophy (wasting of spinal muscles): 3 people, 25.00%
Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 3 people, 25.00%
Mycobacterium Abscessus Infection (rapid growing bacterial infection): 1 person, 8.33%
Infection: 1 person, 8.33%
Immunodeficiency Disorders: 1 person, 8.33%
Escherichia Infection (bacterial infection by escherichia coli): 1 person, 8.33%
Enterococcal Bacteraemia (presence of bacteria lactic acid in the blood): 1 person, 8.33%
Endocarditis (inflammation in heart muscle): 1 person, 8.33%
Cystic Fibrosis (disease of the secretary glands): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cefoxitin and Tazidime?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously